ARCHIVES

“If We Had More Resources, It’s A Fantastic Time” For Cancer Research

This article is from The Cancer Letter archive.

Vol. 21 No. 19 | May 12, 1995

Download PDF Visit The Full Archive

Related Articles

Tamoxfin Trial accrues 6,000, Problems with Minority accrual Remain

April 2, 1993

ODAC Advice Poses Challenge to FDA: Would Iressa Approval Erode Standards?

November 8, 2002

Orphan Designation Granted To Advaxis HPV Immunotherapy

May 30, 2014

ODAC Reviews Post-Marketing Studies for Eight Indications

February 21, 2003

In Washington: Health Groups Urge Congress: No Immunity For Tobacco Industry; Clinton Proposes $400M Effort To End Racial Health Disparities

February 27, 1998

FDA Backs Down, Releases INDs, But Revives Controversy Over Clinical Testing Guidelines

March 12, 1976